Paritaprevir/Ombitasvir/Ritonavir | m-entrepreneurship.com

Product Name :
Paritaprevir/Ombitasvir/Ritonavir

Search keywords :
Paritaprevir

drugId :
null

Target Vo:
Human immunodeficiency virus type 1 protease

Target Vo Short Name :
HIV-1 protease

Moa_Name:
Human immunodeficiency virus type 1 protease inhibitors

First Approval Country :
EU

First Approval Date Filter:
2015

Origin Company_Name :
Abbvie Inc

Active Company_Name :
Abbvie Ag

Active Indication_Name:
Hepatitis C, Chronic

In Active Indication_Name:
HIV Infections

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Filamin A Rabbit mAb Cancer
Glembatumumab Epigenetic Reader Domain
BRCA1 Antibody (YA819): BRCA1 Antibody (YA819) is a non-conjugated and Mouse origined monoclonal antibody about 208 kDa, targeting to BRCA1. It can be used for IHC-P assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts